Dr. Scott Gottlieb to keynote MM+M Transform in April

January 10, 2025

Source: MMM

Former FDA commissioner, Dr. Scott Gottlieb will take the stage for the brand’s 11th annual spring conference.

Dr. Scott Gottlieb, who served as 23rd commissioner of the Food and Drug Administration, will keynote MM+M’s flagship conference — Transform — on April 3.

Gottlieb served as commissioner of the agency under President Donald Trump from 2017 to 2019. Under his leadership, the FDA advanced new frameworks for the modern oversight of gene therapies, cell-based medicines and digital health devices. The agency implemented new reforms to standardize drug reviews and made historic improvements in post-market data collection and the use of real-world evidence.

He promoted policies to reduce death and disease from tobacco, improve food safety and aggressively confront addiction crises. His tenure was also distinguished by a record-setting number of approvals for novel drugs, medical devices and generic medicines.

Gottlieb is currently a senior fellow at the American Enterprise Institute for Public Policy Research and a partner at venture capital firm New Enterprise Associates. He also serves on the board of directors of Pfizer and Illumina.

Interested in attending Transform? Check out the conference’s registration page here. Pharma marketers can receive complimentary passes to attend the event. MM+M will be revealing more speakers in the coming weeks.

The event will take place on April 3, 2025, at the Convene located at 1 Liberty Plaza in New York City.